Education
About Us
Working with TipRanks
Follow Us
Microba Life Sciences Limited (AU:MAP)
ASX:MAP
RESEARCH TOOLSreports
MAP Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MAP Stock 12 Month Forecast
Average Price Target
AU$0.35
▲(75.00% Upside)
| Highest Price TargetAU$0.36 | Average Price TargetAU$0.35 | Lowest Price TargetAU$0.34 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Morgans
Reiterated
02/27/25
Bell Potter
Reiterated
02/26/25
Canaccord Genuity
AU$0.44
Buy
120.00%
Upside
Reiterated
11/01/24
Canaccord Genuity Keeps Their Buy Rating on Microba Life Sciences Limited (MAP)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Morgans
Reiterated
02/27/25
Bell Potter
Reiterated
02/26/25
Canaccord Genuity
AU$0.44
Buy
120.00%
Upside
Reiterated
11/01/24
Canaccord Genuity Keeps Their Buy Rating on Microba Life Sciences Limited (MAP)
MAP Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Nov 24
Jan 25
Feb 25
Strong Buy
3
3
3
2
1
Buy
0
0
0
1
3
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
4
Each month's total comprises the sum of three months' worth of ratings.
MAP Financial Forecast
MAP Stock Forecast FAQ
What is AU:MAP’s average 12-month price target, according to analysts?
Based on analyst ratings, Microba Life Sciences Limited’s 12-month average price target is AU$0.35.
What is AU:MAP’s upside potential, based on the analysts’ average price target?
Microba Life Sciences Limited has 75.00% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Microba Life Sciences Limited a Buy, Sell or Hold?
Microba Life Sciences Limited has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Microba Life Sciences Limited’s share price target?
The average share price target for Microba Life Sciences Limited is AU$0.35. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is AU$0.36 ,and the lowest forecast is AU$0.34. The average share price target represents 75.00% Increase from the current price of AU$0.2.
The highest analyst share price target is AU$0.36 ,and the lowest forecast is AU$0.34. The average share price target represents 75.00% Increase from the current price of AU$0.2.
What do analysts say about Microba Life Sciences Limited?
Microba Life Sciences Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of Microba Life Sciences Limited?
To buy shares of AU:MAP, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.